Ovoca Bio Plc (OVB) Euro 0.125

- Add to watchlist
- Create an alert
- This stock can be held in a




1.40p
1.31p
1.95p
£1.14 million
1.40p
1.31p
0.55p
n/a
0.05p (3.45%) Previous:
0.05p
245
n/a
50,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue (€m) | n/a | n/a |
Profit before tax (€m) | (5.10) | (5.61) |
Adjusted EPS (¢): | (5.76) | (6.88) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: Euro
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Ovoca Bio shares plummet after female libido treatment trial fails
31 August 2023 14:33
-
Ovoca Bio to dispose of Russian assets
8 March 2023 11:45
-
Ovoca Bio enrols participants in women's sexual drug trial
29 July 2022 16:00
-
Result of AGM
18 December 2024 18:00
-
Notice of AGM
18 November 2024 07:00
-
Holding(s) in Company
11 October 2024 17:30
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.